A Comparison of Top Movers: Kadmon Holdings, Inc. (KDMN), Radius Health, Inc. (RDUS)

The shares of Kadmon Holdings, Inc. have increased by more than 1.66% this year alone. The shares recently went up by 9.85% or $0.33 and now trades at $3.68. The shares of Radius Health, Inc. (NASDAQ:RDUS), has slumped by -5.63% year to date as of 06/12/2018. The shares currently trade at $29.98 and have been able to report a change of 4.83% over the past one week.

The stock of Kadmon Holdings, Inc. and Radius Health, Inc. were two of the most active stocks on Tuesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. The ROI of KDMN is 1464.60% while that of RDUS is -61.00%. These figures suggest that KDMN ventures generate a higher ROI than that of RDUS.

Cash Flow

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, KDMN’s free cash flow per share is a negative -0.14, while that of RDUS is also a negative -0.32.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for KDMN is 1.00 and that of RDUS is 6.50. This implies that it is easier for KDMN to cover its immediate obligations over the next 12 months than RDUS.


KDMN currently trades at a P/S of 43.33 while RDUS trades at a P/B of 6.91, and a P/S of 38.07. This means that looking at the earnings, book values and sales basis, KDMN is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of KDMN is currently at a -69.33% to its one-year price target of 12.00. Looking at its rival pricing, RDUS is at a -38.82% relative to its price target of 49.00.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), KDMN is given a 2.00 while 2.20 placed for RDUS. This means that analysts are more bullish on the outlook for RDUS stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for KDMN is 8.05 while that of RDUS is just 16.07. This means that analysts are more bullish on the forecast for KDMN stock.


The stock of Radius Health, Inc. defeats that of Kadmon Holdings, Inc. when the two are compared, with RDUS taking 3 out of the total factors that were been considered. RDUS happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, RDUS is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for RDUS is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

S&P Global Inc. (SPGI) vs. Moody’s Corp... S&P Global Inc. (NYSE:SPGI) shares are up more than 56.95% this year and recently decreased -0.72% or -$1.23 to settle at $168.78. Moody's Corpora...
B&G Foods, Inc. (BGS) Technical Analysis Indi... B&G Foods, Inc. (NYSE:BGS) fell by -2.64% in Thursday’s trading session from $32.15 to $31.30 The stock price went upward in 6 of the last 10 days...
Cerus Corporation (CERS) vs. Pieris Pharmaceutical... Cerus Corporation (NASDAQ:CERS) shares are up more than 44.08% this year and recently increased 1.46% or $0.07 to settle at $4.87. Pieris Pharmaceutic...
Technical Indicators Turn Bullish For Tremor Video... Tremor Video, Inc. (NYSE:TRMR) gained 7.72% in Thursday’s session, going up from its prior closing price of $2.59 to $2.79, and has now recorded rally...
Celldex Therapeutics, Inc. (CLDX) vs. Vical Incorp... Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares are down more than -1.41% this year and recently increased 1.08% or $0.03 to settle at $2.80. Vical In...